Comparison of Dexmedetomidine and propofol on the inflammatory responses in elderly Patients Undergoing Radical Gastrectomy, a randomized controlled trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-15006217

Enrollment

Unknown

Registered

2015-04-09

Start date

2013-10-12

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

group D and group C:Dexmedetomidine and propofol

Eligibility

Sex/Gender

All

Age

60 Years to 85 Years

Inclusion criteria

Inclusion criteria: aged 60 to 80 years, ASA I or II), who did radical gastrectomy under general anesthesia

Exclusion criteria

Exclusion criteria: hemodynamic instability (defined as a systolic blood pressure 5 mg/dL), and known or suspected brain death.

Design outcomes

Primary

Measure	Time frame
pro-inflammatory cytokines;	—

Countries

China

Contacts

Public ContactDandan Feng

dandanstone2012@163.com+86 13813881284

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026